Thursday, November 12, 2026

Nikkei 225 Over 10% Up In The Last 21 Sessions

ViaNews Editorial Team

January 23, 2024

Nikkei 225 Over 10% Up In The Last 21 Sessions

(VIANEWS) - Nikkei 225 (N225) has been up by 10.75% for the last 21 sessions. At 20:08 EST on Monday, 22 January, Nikkei 225 (N225) is $36,791.83.

About Nikkei 225's yearly highs and lows, it's 38.14% up from its 52-week low and 0.23% down from its 52-week high.

Volatility

Nikkei 225's last week, last month's, and last quarter's current intraday variation average was 0.65%, 0.58%, and 0.89%, respectively.

Nikkei 225's highest amplitude of average volatility was 0.86% (last week), 0.86% (last month), and 0.89% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225's is considered to be oversold (<=20).

News about

  • According to DailyForex on Monday, 22 January, "This catalyst could be the ongoing bull run in the stock market now that US indices like the S&P 500 and Nasdaq 100 have surged to a record high. "
  • According to FXStreet on Monday, 22 January, "However, the AUD could cheer the surge in the domestic share market, mirroring a rally in the US that propelled the S&P 500 and the Nasdaq to new records on Friday. "
  • According to Zacks on Monday, 22 January, "Between its January 2022 high and the October low, the S&P 500 had fallen 25% and was in the bear region. ", "Advancing issues outnumbered the declining ones on the S&P 500 by a 2.9-to-one ratio. "
  • According to DailyForex on Monday, 22 January, "At the same time, the main indices like the Dow Jones, Nasdaq 100, and S&P 500 indices continued rallying and moved to their all-time highs. "
  • According to Zacks on Monday, 22 January, "NRG Energy's current dividend yield is 2.88%, higher than the Zacks S&P 500 Composite's average of 1.36%."

More news about Nikkei 225 (N225).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com